EA202192305A1 - Новая рекомбинантная диаминоксидаза и её применение для лечения заболеваний, характеризующихся избытком гистамина - Google Patents
Новая рекомбинантная диаминоксидаза и её применение для лечения заболеваний, характеризующихся избытком гистаминаInfo
- Publication number
- EA202192305A1 EA202192305A1 EA202192305A EA202192305A EA202192305A1 EA 202192305 A1 EA202192305 A1 EA 202192305A1 EA 202192305 A EA202192305 A EA 202192305A EA 202192305 A EA202192305 A EA 202192305A EA 202192305 A1 EA202192305 A1 EA 202192305A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- histamine
- dao
- excess
- diamine oxidase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
- C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
- C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
- C12Y104/03022—Diamine oxidase (1.4.3.22)
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/20—Sequence assembly
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
- G16B35/10—Design of libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Library & Information Science (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19157932 | 2019-02-19 | ||
| PCT/EP2020/054197 WO2020169577A1 (en) | 2019-02-19 | 2020-02-18 | New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202192305A1 true EA202192305A1 (ru) | 2021-12-08 |
Family
ID=65493995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202192305A EA202192305A1 (ru) | 2019-02-19 | 2020-02-18 | Новая рекомбинантная диаминоксидаза и её применение для лечения заболеваний, характеризующихся избытком гистамина |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220145269A1 (enExample) |
| EP (1) | EP3927817B1 (enExample) |
| JP (1) | JP7792252B2 (enExample) |
| KR (1) | KR20210132650A (enExample) |
| CN (1) | CN113785052B (enExample) |
| AU (1) | AU2020225319B2 (enExample) |
| BR (1) | BR112021015865A2 (enExample) |
| CA (1) | CA3130751A1 (enExample) |
| EA (1) | EA202192305A1 (enExample) |
| ES (1) | ES3041133T3 (enExample) |
| IL (1) | IL285452B2 (enExample) |
| MX (1) | MX2021010050A (enExample) |
| SG (1) | SG11202107659SA (enExample) |
| WO (1) | WO2020169577A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10947552B1 (en) | 2020-09-30 | 2021-03-16 | Alpine Roads, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
| WO2022072718A1 (en) | 2020-09-30 | 2022-04-07 | Nobell Foods, Inc. | Recombinant milk proteins and food compositions comprising the same |
| US10894812B1 (en) | 2020-09-30 | 2021-01-19 | Alpine Roads, Inc. | Recombinant milk proteins |
| EP4496488A4 (en) * | 2022-03-21 | 2025-11-26 | Cedars Sinai Medical Center | METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE INTESTINAL MICROBIOME |
| IL317379A (en) * | 2022-06-03 | 2025-02-01 | Oyster Point Pharma Inc | AAV vector encoding diamine oxidase and its uses |
| EP4782002A1 (en) * | 2025-01-27 | 2026-07-29 | DR Healthcare S.L.U. | Diamine oxidase (dao) for use in the treatment of infertility |
| CN121975758B (zh) * | 2026-04-02 | 2026-07-14 | 华中科技大学同济医学院附属同济医院 | 组胺氧化酶蛋白及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK402785D0 (da) * | 1985-09-03 | 1985-09-03 | Syn Tek Ab | Fremgangsmaade til fremstilling af et enzym |
| US6075007A (en) * | 1997-07-17 | 2000-06-13 | Regeneron Pharmaceuticals, Inc. | Modified noggin polypeptide and compositions |
| IT1317067B1 (it) * | 2000-11-29 | 2003-05-26 | Univ Roma | Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico. |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| CA2536016C (en) * | 2002-08-16 | 2017-01-10 | Paul L. Deangelis | Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| US20050255114A1 (en) * | 2003-04-07 | 2005-11-17 | Nuvelo, Inc. | Methods and diagnosis for the treatment of preeclampsia |
| AT502098B8 (de) * | 2004-07-07 | 2007-06-15 | Albert Dr Missbichler | Diaminooxidase-hältige zusammensetzung |
| CA2660286A1 (en) * | 2006-08-09 | 2008-02-21 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| WO2012028891A1 (en) * | 2010-09-02 | 2012-03-08 | Debreceni Egyetem | Perorally applicable preparation containing histaminase of vegetable origin, resistant to pepsin and trypsin and a process for producing it |
| JP2014518632A (ja) * | 2011-06-01 | 2014-08-07 | モアハウス スクール オブ メディスン | ケモカイン−免疫グロブリン融合ポリペプチド、組成物、その作製および使用の方法 |
| AU2015332533B2 (en) * | 2014-10-14 | 2018-08-30 | Halozyme, Inc. | Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same |
| WO2023122254A2 (en) * | 2021-12-22 | 2023-06-29 | The Board Of Trustees Of The Leland Stanford Junior University | Methods to elicit desire to mate and mating behavior |
-
2020
- 2020-02-18 JP JP2021548232A patent/JP7792252B2/ja active Active
- 2020-02-18 WO PCT/EP2020/054197 patent/WO2020169577A1/en not_active Ceased
- 2020-02-18 CA CA3130751A patent/CA3130751A1/en active Pending
- 2020-02-18 SG SG11202107659SA patent/SG11202107659SA/en unknown
- 2020-02-18 AU AU2020225319A patent/AU2020225319B2/en active Active
- 2020-02-18 BR BR112021015865-0A patent/BR112021015865A2/pt unknown
- 2020-02-18 CN CN202080020112.7A patent/CN113785052B/zh active Active
- 2020-02-18 EP EP20704547.7A patent/EP3927817B1/en active Active
- 2020-02-18 US US17/430,714 patent/US20220145269A1/en active Pending
- 2020-02-18 ES ES20704547T patent/ES3041133T3/es active Active
- 2020-02-18 MX MX2021010050A patent/MX2021010050A/es unknown
- 2020-02-18 EA EA202192305A patent/EA202192305A1/ru unknown
- 2020-02-18 IL IL285452A patent/IL285452B2/en unknown
- 2020-02-18 KR KR1020217024580A patent/KR20210132650A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES3041133T3 (en) | 2025-11-07 |
| EP3927817C0 (en) | 2025-08-20 |
| AU2020225319B2 (en) | 2025-05-29 |
| KR20210132650A (ko) | 2021-11-04 |
| US20220145269A1 (en) | 2022-05-12 |
| BR112021015865A2 (pt) | 2021-10-05 |
| SG11202107659SA (en) | 2021-09-29 |
| WO2020169577A1 (en) | 2020-08-27 |
| CA3130751A1 (en) | 2020-08-27 |
| EP3927817B1 (en) | 2025-08-20 |
| CN113785052A (zh) | 2021-12-10 |
| IL285452B2 (en) | 2025-07-01 |
| CN113785052B (zh) | 2024-06-28 |
| IL285452A (en) | 2021-09-30 |
| MX2021010050A (es) | 2021-09-21 |
| JP2022520862A (ja) | 2022-04-01 |
| EP3927817A1 (en) | 2021-12-29 |
| AU2020225319A1 (en) | 2021-10-14 |
| IL285452B1 (en) | 2025-03-01 |
| JP7792252B2 (ja) | 2025-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021010050A (es) | Nueva diamino oxidasa recombinante y su uso para el tratamiento de enfermedades caracterizadas por exceso de histamina. | |
| WO2008134659A8 (en) | Antagonists to il-17a, il-17f, and il-23p19 and methods of use | |
| WO2014164959A3 (en) | Anti-il-33 antibodies and uses thereof | |
| WO2010065072A8 (en) | Antagonists of il-6 to raise albumin and/or lower crp | |
| EA202193351A1 (ru) | Связывающая молекула, специфическая в отношении cd73, и применение связывающей молекулы | |
| NO20082942L (no) | Ligander som binder IL-4 og/eller IL-13 | |
| NO20070153L (no) | Loselig zcytorl4, anti-zcytorl4-antistoffer og bindingspartnere og fremgangsmater for anvendelse ved inflammasjon | |
| EA201890453A1 (ru) | Анти-angptl8 антитела и их применение | |
| EA201100302A1 (ru) | Лечение диабета у пациентов, для которых лечение метформином является неприемлемым | |
| Albrecht et al. | Expression and function of histamine and its receptors in atopic dermatitis | |
| MY146664A (en) | Antibodies against human il-22 and uses therefor | |
| PH12013500564A1 (en) | Anti-cd48 antibodies and uses thereof | |
| NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
| DK2185937T4 (da) | Fremgangsmåde til at bestemme sepsis hos mennesker | |
| EA201070231A1 (ru) | Иммуномодулирующие пептиды | |
| WO2018060739A3 (en) | Assay for distinguishing between sepsis and systemic inflammatory response syndrome | |
| Yang et al. | Effect of cleaning agents and additives on Protein A ligand degradation and chromatography performance | |
| EA201100653A1 (ru) | Лиганды, связывающиеся с интерлейкином-13 (il-13) | |
| JP2024154382A5 (enExample) | ||
| JOP20190271A1 (ar) | بروتينات مطعّمة بسيتوكين- الجسم المضاد وطرق الاستخدام للاضطرابات المتعلقة بالمناعة | |
| NO20063969L (no) | Redusjon av akrylamid i ferdigmat | |
| EP4349917A4 (en) | Manufacturing method for polyether-polysiloxane block copolymer composition, polyether-polysiloxane block copolymer composition, and use therefor | |
| MX2021007116A (es) | Biomarcadores y usos en el tratamiento de infecciones virales, inflamaciones o cancer. | |
| Tehrani et al. | IMMUNOCHEMICAL CHARACTERIZATION OF AMARANTHUS RETROFLEX US POLLEN EXTRACT: EXTENSIVE CROSS-REACTIVE ALLERGENIC COMPONENTS AMONG THE FOUR SPECIES OF AMARANTHACEAE/CHENOPODIACEAE | |
| WO2005101838A8 (en) | Piperazinylpiperidine derivatives as chemokine receptor antagonists |